their ease of oral administration , favourable pharmacokinetics , low incidence of adverse reactions , and broad spectrum of in vitro activity against aerobic and facultative organisms make them especially suitable for treating bacteriuria , particularly when pathogens are resistant to other available oral agents .
C0029235
organisms
C0450254
pathogens